Biodesix Financials - Benzinga

Biodesix Inc

BDSXNASDAQ

Trade with Public

Trade with Public

$24.51

1.265.42%

At close: Aug 18, 5:00 PM EST

$24.51

1.265.42%

After Hours: Aug 14, 8:51 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Biodesix Financials

Biodesix (BDSX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Biodesix Affirms FY2026 Sales Guidance of $108.000M-$114.000M vs $110.996M Est

Biodesix (NASDAQ:BDSX) affirms FY2026 sales outlook from $108.000 million-$114.000 million to $108.000 million-$114.000 million vs $110.996 million estimate.

Benzinga Newsdesk

PRO
Biodesix Q2 EPS $(0.71) Beats $(0.91) Estimate, Sales $26.861M Beat $26.026M Estimate

Benzinga Newsdesk

PRO
Biodesix Raises FY2026 Sales Guidance from $106.000M-$112.000M to $108.000M-$114.000M vs $108.680M Est

Biodesix (NASDAQ:BDSX) raises FY2026 sales outlook from $106.000 million-$112.000 million to $108.000 million-$114.000 million vs $108.680 million estimate.

Benzinga Newsdesk

PRO
Biodesix Q1 EPS $(0.81) Beats $(1.12) Estimate, Sales $25.555M Beat $23.178M Estimate

Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(1.12) by 27.68 percent. This is a 49.38 percent increase over losses of $(1.60) per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 4, 2026

Benzinga Insights

Biodesix Earnings Report: Q4 Overview

Benzinga Insights